biblio

Export 140 results:
Filters: Author is Sarkar, Dhiman  [Clear All Filters]
2023
S. Singh, Navale, G. R., Agrawal, S., Singh, H. Kisan, Singla, L., Sarkar, D., Sarma, M., Choudhury, A. Roy, and Ghosh, K., “Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid ? (1-42) peptide aggregation”, International Journal of Biological Macromolecules, vol. 239, p. 124197, 2023.
R. Mamgain, Swami, S., Sarkar, D., and Srivastava, P., “Design, synthesis, and in vitro biological evaluation of ROS-generating phenanthridin-trione-epoxide conjugates as agents against mycobacterium tuberculosis”, ChemistrySelect, vol. 8, no. 25, p. e202300416, 2023.
R. Saini, Navale, G. R., Singh, S., Singh, H. Kisan, Chauhan, R., Agrawal, S., Sarkar, D., Sarma, M., and Ghosh, K., “Inhibition of amyloid β1-42 peptide aggregation by newly designed cyclometallated palladium complexes”, International Journal of Biological Macromolecules, vol. 248, p. 125847, 2023.
A. Dangi, Pande, B., Agrawal, S., Sarkar, D., Vamkudoth, K. Rao, and Marelli, U. Kiran, “Total synthesis, structure elucidation and expanded bioactivity of icosalide A: effect of lipophilicity and ester to amide substitution on its bioactivity”, Organic & Biomolecular Chemistry, vol. 21, no. 28, pp. 5725-5731, 2023.
2022
D. D. Subhedar, Shaikh, M. H., Nagargoje, A. A., V. Akolkar, S., Bhansali, S. G., Sarkar, D., and Shingate, B. B., “Amide-linked monocarbonyl curcumin analogues: efficient synthesis, antitubercular activity and molecular docking study”, Polycyclic Aromatic Compounds, vol. 45, no. 5, pp. 2655-2671, 2022.
N. C. Desai, Bhatt, K., Jadeja, D. J., Mehta, H. K., Khedkar, V. M., and Sarkar, D., “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
D. D. Subhedar, Shaikh, M. H., Nagargoje, A. A., Sarkar, D., Khedkar, V. M., and Shingate, B. B., “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.
S. Sarkar, Swami, S., Soni, S. Kumar, Holien, J. K., Khan, A., Korwar, A. M., Likhite, A. P., Joshi, R. A., Joshi, R. R., and Sarkar, D., “Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols”, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.
G. Navale, Singh, S., Agrawal, S., Ghosh, C., Choudhury, A. Roy, Roy, P., Sarkar, D., and Ghosh, K., “DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(ii) complexes”, Dalton Transactions, vol. 51, no. 42, pp. 16371-16382, 2022.
A. Yeware, Akhtar, S., and Sarkar, D., “Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay”, Medicine in Drug Discovery, vol. 13, p. 100115, 2022.
J. L. Nalawade, Mhaske, P. C., Shinde, A. D., Chavan, A. P., Abhale, Y. K., Sarkar, D., and Bobade, V. D., “Synthesis and antimycobacterial screening of a novel series of alpha-amino acids containing thiazole linker”, ARKIVOC, 2022.
S. M. Jagadale, Abhale, Y. K., Pawar, H. R., Shinde, A., Bobade, V. D., Chavan, A. P., Sarkar, D., and Mhaske, P. C., “Synthesis of new thiazole and pyrazole clubbed 1,2,3-triazol derivatives as potential antimycobacterial and antibacterial agents”, Polycyclic Aromatic Compounds, vol. 42, no. 6, pp. 3216-3237, 2022.
M. H. Shaikh, Subhedar, D. D., Akolkar, S. V., Nagargoje, A. A., Khedkar, V. M., Sarkar, D., and Shingate, B. B., “Tetrazoloquinoline-1,2,3-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking study”, Polycyclic Aromatic Compounds, vol. 42, no. 4, pp. 1920-1941, 2022.
V. S. Honmore, Natu, A. D., Khedkar, V. M., Arkile, M. A., Sarkar, D., and Rojatkar, S. R., “Two antibacterial spiro compounds from the roots of Artemisia pallens wall: evidence from molecular docking”, Natural Product Research, vol. 36, no. 10, pp. 2465-2472, 2022.
2021
R. Balasaheb Aher and Sarkar, D., “2D-QSAR modeling and two-fold classification of 1,2,4-triazole derivatives for antitubercular potency against the dormant stage of Mycobacterium tuberculosis”, Molecular Diversity, vol. 26, no. 2, pp. 1227-1242, 2021.
T. S. Chitre, Asgaonkar, K. D., Vikhe, A. B., Patil, S. M., Garud, D. R., Khedkar, V. M., Sarkar, D., Nawale, L. U., and Yeware, A., “In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives”, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.
V. Honmore, Kalyankar, V., Natu, A., Khedkar, V., Sarkar, D., and Rojatkar, S., “In vitro antitubercular screening and in silico study of germacradienolide from blainvillea latifolia”, Asian Journal of Chemistry, vol. 33, no. 12, pp. 3129-3133, 2021.
S. Agrawal, Gample, S., Yeware, A., and Sarkar, D., “Novel gene similar to nitrite reductase (NO forming) plays potentially important role in the latency of tuberculosis”, Scientific Reports, vol. 11, no. 1, p. 19813, 2021.
R. Balasaheb Aher and Sarkar, D., “Online tools and antiviral databases for the development of drugs against coronaviruses”, in In Silico Modeling of Drugs Against Coronaviruses: Computational Tools and Protocols, K. Roy, Ed. New York, NY: Springer US, 2021, pp. 717–734.
R. Balasaheb Aher and Sarkar, D., “Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis”, Journal of Biomolecular Structure & Dynamics, vol. 39, no. 3, pp. 889-900, 2021.
M. M. Pisal, Annadate, R. A., Athalye, M. C., Kumar, D., Chavan, S. P., Sarkar, D., and Borate, H. B., “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocyclyl-2,6-dicyanoanilines (vol 27, pg 979, 2017)”, Bioorganic & Medicinal Chemistry Letters, vol. 32, p. 127737, 2021.
Y. K. Abhale, Shinde, A., Shelke, M., Nawale, L., Sarkar, D., and Mhaske, P. C., “Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents”, Bioorganic Chemistry, vol. 115, p. 105192, 2021.
2020
S. B. Nadhe, Tawre, M. S., Agrawal, S., Chopade, B. A., Sarkar, D., and Pardesi, K., “Anticancer potential of AgNPs synthesized using acinetobacter sp. and curcuma aromatica against HeLa cell lines: a comparative study”, Journal of Trace Elements in Medicine and Biology, vol. 62, p. 126630, 2020.
S. Waghmode, Swami, S., Sarkar, D., Suryavanshi, M., Roachlani, S., Choudhari, P., and Satpute, S., “Exploring the pharmacological potentials of biosurfactant derived from planococcus maritimus SAMP MCC 3013”, Current Microbiology, vol. 77, no. 3, pp. 452-459, 2020.
P. P. Thakare, Walunj, Y., Chavan, A., Bobade, V. D., Sarkar, D., and Mhaske, P. C., “Synthesis and antimycobacterial screening of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-3-yl)quinoline derivatives”, Journal of Heterocyclic Chemistry, vol. 57, no. 11, pp. 3918-3929, 2020.
2019
, ,, Wadgaonkar, P. P., Tapase, S. R., Kodam, K. M., Choudhari, A., and Sarkar, D., “Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents”, Bioorganic Chemistry, vol. 85, pp. 475-486, 2019.
S. B. Baravkar, Wagh, M. A., Nawale, L. U., Choudhari, A. S., Bhansali, S., Sarkar, D., and Sanjayan, G. J., “Design and synthesis of 2-amino-thiophene-proline-conjugates and their anti-tubercular activity against mycobacterium tuberculosis H37Ra”, ChemistrySelect, vol. 4, no. 9, pp. 2851-2857, 2019.
A. Atmaram Upare, Gadekar, P. K., Sivaramakrishnan, H., Naik, N., Khedkar, V. M., Sarkar, D., Choudhari, A., and S. Roopan, M., “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
S. P. Gample, Agrawal, S., and Sarkar, D., “Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance”, Scientific Reports, vol. 9, p. 9261, 2019.
A. Yeware, Agrawal, S., and Sarkar, D., “High content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis”, Journal of Microbiological Methods, vol. 164, 2019.
T. S. Chitre, Patil, S. M., Sujalegaonkar, A. G., Asgaonkar, K. D., Khedkar, V. M., Garud, D. R., Jha, P. C., Gaikwad, S. Y., Kulkarni, S., Choudhari, A., and Sarkar, D., “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
P. Miniyar, Mahajan, A., Anuse, D., Kumar, A., Barmade, M., Sarkar, D., Arkile, M., and Khedkar, V., “Recursive partitioning analysis and anti-tubercular screening of 3-aminopyrazine-2-carbohydrazide derivatives”, Letters in Drug Design & Discovery, vol. 16, no. 11, pp. 1264-1275, 2019.
V. Shinde, Mahulikar, P., Mhaske, P. C., Chakraborty, S., Choudhari, A., Phalle, S., Choudhari, P., and Sarkar, D., “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
U. B. Karale, Krishna, V. Siva, E. Krishna, V., Choudhari, A. S., Shukla, M., Gaikwad, V. R., Mahizhaveni, B., Chopra, S., Misra, S., Sarkar, D., Sriram, D., Dusthackeer, V. N. Azger, and Rode, H. B., “Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis”, European Journal of Medicinal Chemistry, vol. 178, pp. 315-328, 2019.
V. Shinde, Mhaske, P. C., Singh, A., Sarkar, D., and Mahulikar, P., “Synthesis and biological evaluation of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole derivatives”, Journal of Heterocyclic Chemistry, 2019.
A. P. Chavan, Deshpande, R. R., Borade, N. A., Shinde, A., Mhaske, P. C., Sarkar, D., and Bobade, V. D., “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
S. J. Takate, Shinde, A. D., Karale, B. K., Akolkar, H., Nawale, L., Sarkar, D., and Mhaske, P. C., “Thiazolyl-pyrazole derivatives as potential antimycobacterial agents”, Bioorganic & Medicinal Chemistry Letters, vol. 29, no. 10, pp. 1199-1202, 2019.
A. Yeware, Gample, S., Agrawal, S., and Sarkar, D., “Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis”, Plos One, vol. 14, no. 8, p. e0220628, 2019.
2018
G. S. Bhosle, Nawale, L., Yeware, A. M., Sarkar, D., and Fernandes, M., “Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life”, European Journal of Medicinal Chemistry, vol. 152, pp. 358-369, 2018.
A. S. Kotmale, Sangtani, E., Gonnade, R. G., Sarkar, D., Burade, S., Rajamohanan, P. R., and Sanjayan, G. J., “Conformational studies of Ant-Pro motif-incorporated cyclic peptides: gramicidin S and avellanin”, New Journal of Chemistry, vol. 42, no. 2, pp. 1197-1201, 2018.
M. A. Wagh, Baravkar, S. B., Jedhe, G. S., Borkute, R., Choudhari, A. S., Sarkar, D., and Sanjayan, G. J., “Design and synthesis of 2-amino-thiophene-tethered ureidopenicillin analogs with potentantibacterial and antitubercular activity”, ChemistrySelect, vol. 3, no. 11, pp. 3122-3126, 2018.
M. S. Tambe, Choudhari, A., Sarkar, D., Sangshetti, J., Patil, R., and Gholap, S. S., “Design, synthesis and biological screening of novel 1,3,4-oxadiazoles as antitubercular agents”, Chemistryselect, vol. 3, no. 47, pp. 13304-13310, 2018.
S. Gholap, Tambe, M., Nawale, L., Sarkar, D., Sangshetti, J., and Damale, M., “Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents”, Archiv Der Pharmazie, vol. 351, no. 2, p. e1700294, 2018.
R. Gawali, Trivedi, J., Bhansali, S., Bhosale, R., Sarkar, D., and Mitra, D., “Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors”, European Journal of Medicinal Chemistry, vol. 157, pp. 310-319, 2018.
N. V. Puranik, Srivastava, P., Swami, S., Choudhari, A., and Sarkar, D., “Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against mycobacterium tuberculosis”, RSC Advances, vol. 8, no. 19, pp. 10634-10643, 2018.
M. H. Shaikh, Subhedar, D., Nawale, L., Sarkar, D., Khan, F. A. Kalam, Sangshetti, J., and Shingate, B. B., “Novel benzylidenehydrazide-1,2,3-triazole conjugates as antitubercular agents: synthesis and molecular docking”, Mini Reviews in Medicinal Chemistry, vol. 18, 2018.
A. Yeware and Sarkar, D., “Novel red fluorescence protein based microplate assay for drug screening against dormant mycobacterium tuberculosis by using paraffin”, Tuberculosis, vol. 110, pp. 15-19, 2018.
H. M. Mali, Sabale, S. S., Degani, M. S., Borkute, R., Choudhari, A. S., Sarkar, D., Krishna, V. Siva, and Sriram, D., “ Rational design of coumarin derivatives as antituberculosis agents”, Future Medicinal Chemistry, vol. 10, no. 20, pp. 2431-2444, 2018.
V. Shinde, Mahulikar, P., Mhaske, P. C., Nawale, L., and Sarkar, D., “Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives”, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.
A. B. Danne, “Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents”, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.
Y. Patil and Shingare, R., “Synthesis and biological evaluation of some bicyclic [2-(2,4-dimethylphenylthio)phenyl] aniline and its amide derivatives as potential antitubercular agents”, Journal of Chemical Sciences, vol. 130, no. 3, p. 22, 2018.
Y. Patil, Shingare, R., Choudhari, A., Borkute, R., Sarkar, D., and Madje, B. R., “Synthesis and biological evaluation of some new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives as potential antitubercular agents”, Archiv Der Pharmazie, vol. 351, no. 8, p. e1800040, 2018.
N. C. Desai, “Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1,3,4-oxadiazoles as potential antituberculars”, Synthetic Communications, vol. 48, no. 5, pp. 524-540, 2018.
A. B. Danne, Choudhari, A. S., Chakraborty, S., Sarkar, D., Khedkar, V. M., and Shingate, B. B., “Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking”, MedChemComm, vol. 9, no. 7, pp. 1114-1130, 2018.
U. D. Nimbalkar, Seijas, J. A., Borkute, R., Damale, M. G., Sangshetti, J. N., Sarkar, D., and Nikalje, A. Pratima G., “Ultrasound assisted synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) benzamide as challenging anti-tubercular scaffold”, Molecules, vol. 23, no. 8, p. Article No: 1945, 2018.
2017
L. Nawale, Dubey, P., Chaudhari, B., Sarkar, D., and Prabhune, A., “Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa”, Plos One, vol. 12 , no. 4, p. e0174241, 2017.
N. Tiwari, Nawale, L. U., Sarkar, D., and Badiger, M. V., “Carboxymethyl cellulose-grafted mesoporous silica hybrid nanogels for enhanced cellular uptake and release of curcumin”, Gels, vol. 3, no. 1, 2017.
P. V. Chavan, Pandit, K. S., Desai, U. V., Wadgaonkar, P. P., Nawale, L., Bhansali, S., and Sarkar, D., “Click-chemistry-based multicomponent condensation approach for design and synthesis of spirochromene-tethered 1,2,3-triazoles as potential antitubercular agents”, Research on Chemical Intermediates, vol. 43, no. 10, pp. 5675-5690, 2017.
M. M. Pisal, Nawale, L. U., Patil, M., Bhansali, S. G., Gajbhiye, J. M., Sarkar, D., Chavan, S. P., and Borate, H. B., “Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies”, European Journal of Medicinal Chemistry, vol. 127, 2017.
P. Nigam Joshi, Agawane, S., Agawane, S., Agawane, S., Sarkar, D., and Sarkar, D., “Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy”, Material Science and Engineering C- Materials for Biological Application, vol. 78, 2017.
P. Nigam Joshi, Agawane, S., Agawane, S., Agawane, S., Sarkar, D., and Sarkar, D., “Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy”, Material Science and Engineering C- Materials for Biological Application, vol. 78, 2017.
M. B. Bhalerao, Dhumal, S. T., Deshmukh, A. R., Nawale, L. U., Khedkar, V. M., Sarkar, D., and Mane, R. A., “New bithiazolyl hydrazones: novel synthesis, characterization and antitubercular evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 2, pp. 288–294, 2017.
D. D. Subhedar, Shaikh, M. H., Nawale, L. U., Sarkar, D., Khedkar, V. M., and Shingate, B. B., “Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: synthesis and molecular docking study”, Bioorganic & medicinal chemistry letters, vol. 27, no. 4, pp. 922-928, 2017.
D. D. Subhedar, Shaikh, M. H., Shingate, B. B., Nawale, L., Sarkar, D., Khedkar, V. M., Khan, F. A. Kalam, and Sangshetti, J. N., “Quinolidene-rhodanine conjugates: facile synthesis and biological evaluation”, European Journal of Medicinal Chemistry, vol. 125, pp. 385–399, 2017.
A. M. Yeware, Shurpali, K. D., Athalye, M. C., and Sarkar, D., “Superoxide generation and its involvement in the growth of mycobacterium smegmatis”, Frontiers in Microbiology, vol. 8, p. Article Number: 105, 2017.
Y. K. Abhale, Sasane, A. V., Chavan, A. P., Shekh, S. Husen, Deshmukh, K. K., Bhansali, S., Nawale, L., Sarkar, D., and Mhaske, P. C., “Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives”, European Journal of Medicinal Chemistry, vol. 132, pp. 333-340, 2017.
S. T. Dhumal, Deshmukh, A. R., Khillare, L. D., Arkile, M. A., Sarkar, D., and Mane, R. A., “Synthesis and antitubercular activity of new thiazolidinones with pyrazinyl and thiazolyl scaffolds”, Journal of Heterocyclic Chemistry, vol. 54, no. 1, pp. 125-130, 2017.
A. Sonawane, Rode, N. D., Nawale, L. U., Joshi, R. R., Joshi, R. A., Likhite, A. P., and Sarkar, D., “Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as anti-mycobacterial agents”, Chemical Biology & Drug Design, vol. 90, no. 2, pp. 200-209, 2017.
J. M. Divse, Mhaske, S. B., Charolkar, C. R., Sant, D. G., Tupe, S. G., Deshpande, M. V., Khedkar, V. M., Nawale, L. U., Sarkar, D., and Pore, V. S., “Synthesis and biological evaluation of new fluconazole β-lactam conjugates linked via 1,2,3-triazole”, New Journal of Chemistry, vol. 41, no. 2, pp. 470-479, 2017.
M. M. Pisal, Annadate, R. A., Athalye, M. C., Kumar, D., Chavan, S. P., Sarkar, D., and Borate, H. B., “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocycl- yl-2,6-dicyanoanilines”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 4, pp. 979-988, 2017.
Y. K. Abhale, Shinde, A. D., Deshmukh, K. K., Nawale, L. U., Sarkar, D., Choudhari, P. B., Kumbhar, S. S., and Mhaske, P. C., “Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives”, Medicinal Chemistry Research, 2017.
N. D. Rode, Sonawane, A. D., Nawale, L., Khedkar, V. M., Joshi, R. A., Likhite, A. P., Sarkar, D., and Joshi, R. R., “Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis”, Chemical Biology & Drug Design, vol. 90, no. 6, pp. 1206-1214, 2017.
M. H. Shaikh, Subhedar, D. D., Khan, F. A. Kalam, Sangshetti, J. N., Nawale, L., Arkile, M. A., Sarkar, D., and Shingate, B. B., “Synthesis of novel triazole-incorporated isatin derivatives as antifungal, antitubercular, and antioxidant agents and molecular docking study”, Journal of Heterocyclic Chemistry, vol. 54, no. 413, 2017.
2016
P. K. Gadekar, Roychowdhury, A., Kharkar, P. S., Khedkar, V. M., Arkile, M. A., Manek, H., Sarkar, D., Sharma, R., Vijayakumar, V., and Sarveswari, S., “Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents”, European Journal of Medicinal Chemistry, vol. 122, pp. 475-487, 2016.
D. D. Subhedar, Shaikh, M. H., Nawale, L., Yeware, A., Sarkar, D., and Shingate, B. B., “[Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity”, Research on Chemical Intermediates, vol. 42, no. 8, pp. 6607-6626, 2016.
D. D. Subhedar, Shaikh, M. H., Arkile, M. A., Yeware, A., Sarkar, D., and Shingate, B. B., “Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1704-1708, 2016.
P. Nigam Joshi, Kundu, S., Sanghi, S. K., and Sarkar, D., “Graphene quantum dots - from emergence to nanotheranostic applications”, in Smart Drug Delivery System, Croatia: Intech, 2016.
S. Pal, Ramu, V., Taye, N., Mogare, D. G., Yeware, A. M., Sarkar, D., D. Reddy, S., Chattopadhyay, S., and Das, A., “GSH Induced controlled release of levofloxacin from a purpose-built prodrug: luminescence response for probing the drug release in escherichia coli and staphylococcus aureus”, Bioconjugate Chemistry, vol. 27, no. 9, pp. 2062-2070, 2016.
V. S. Honmore, Rojatkar, S. R., Nawale, L. U., Arkile, M. A., Khedkar, V. M., Natu, A. D., and Sarkar, D., “In vitro and ex vivo antitubercular activity of diarylheptanoids from the rhizomes of alpinia officinarum hance”, Natural Product Research, vol. 30, no. 24, pp. 2825-2830, 2016.
V. S. Honmore, Kandhare, A. D., Kadam, P. P., Khedkar, V. M., Sarkar, D., Bodhankar, S. L., Zanwar, A. A., Rojatkar, S. R., and Natu, A. D., “Isolates of alpinia officinarum hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies”, International Immunopharmacology, vol. 33, pp. 8-17, 2016.
T. R. Valkute, Arkile, M. A., Sarkar, D., and Bhattacharya, A. K., “Naturally occurring anti-TB agents: isolation, chemical transformations and in vitro antitubercular activities of secondary metabolites of rhizomes of alpinia galanga”, Planta Medica International Open, vol. 3, no. 3, pp. e55-e59, 2016.
A. A. Chinchansure, Arkile, M. A., Shinde, D. R., Sarkar, D., and Joshi, S. P., “New dinor-cis-labdane diterpene and flavonoids with antimycobacterium activity from colebrookea oppositifolia”, Planta Medica Letters, vol. 3, no. 1, pp. e20-e24, 2016.
R. R. Kulkarni, Shurpali, K., Khedkar, V. M., Puranik, V. G., Sarkar, D., and Joshi, S. P., “New pimarane diterpenes and other antimycobacterial metabolites from anisochilus verticillatus”, Natural Product Research, vol. 30, no. 6, pp. 675-681, 2016.
D. D. Subhedar, Shaikh, M. H., Nawale, L., Yeware, A., Sarkar, D., Khan, F. A. Kalam, Sangshetti, J. N., and Shingate, B. B., “Novel tetrazoloquinoline-rhodanine conjugates: highly efficient synthesis and biological evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2278-2283, 2016.
D. D. Subhedar, Shaikh, M. H., Shingate, B. B., Nawale, L., Sarkar, D., and Khedkar, V. M., “Novel tetrazoloquinoline-thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking”, Medchemcomm, vol. 7, no. 9, pp. 1832-1848, 2016.
R. Singh, Nawale, L., Arkile, M. A., Wadhwani, S., Shedbalkar, U., Chopade, S., Sarkar, D., and Chopade, B. Ananda, “Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents”, International Journal of Nanomedicine, vol. 11, p. 1889—1897, 2016.
P. R. Sharma, Kamble, S., Sarkar, D., Anand, A., and Varma, A., “Shape and size engineered cellulosic nanomaterials as broad spectrum anti-microbial compounds”, International Journal of Biological Macromolecules, vol. 87, pp. 460-465, 2016.
S. T. Dhumal, Deshmukh, A. R., Bhosle, M. R., Khedkar, V. M., Nawale, L. U., Sarkar, D., and Mane, R. A., “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
P. S. Mahajan, Nikam, M. D., Nawale, L. U., Khedkar, V. M., Sarkar, D., and Gill, C. H., “Synthesis and antitubercular activity of new benzo[b]thiophenes”, ACS Medicinal Chemistry Letters, vol. 7, no. 8, pp. 751-756, 2016.
M. H. Shaikh, Subhedar, D. D., Arkile, M. A., Khedkar, V. M., Jadhav, N. J., Sarkar, D., and Shingate, B. B., “Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 2, pp. 561-569, 2016.
T. S. Chitre, Asgaonkar, K. D., Miniyar, P. B., Dharme, A. B., Arkile, M. A., Yeware, A., Sarkar, D., Khedkar, V. M., and Jha, P. C., “Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2224-2228, 2016.
H. B. Borate, Annadate, R. A., Vagh, S. S., Pisal, M. M., Deokate, S. B., Arkile, M. A., Jadhav, N. J., Nawale, L. U., and Sarkar, D., “Synthesis and evaluation of thieno[2,3-d]pyrimidin-4(3H)-ones as potential antitubercular agents (vol 6, pg 2209, 2015)”, Medchemcomm, vol. 7, no. 2, p. 379, 2016.
T. Ismail, Shafi, S., Srinivas, J., Sarkar, D., Qurishi, Y., Khazir, J., Alam, M. Sarwar, and Kumar, H. Mahabalara, “Synthesis and tyrosinase inhibition activity of trans-stilbene derivatives”, Bioorganic Chemistry, vol. 64, pp. 97-102, 2016.
M. H. Shaikh, Subhedar, D. D., Shingate, B. B., Khan, F. A. Kalam, Sangshetti, J. N., Khedkar, V. M., Nawale, L., Sarkar, D., Navale, G. R., and Shinde, S. S., “Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents”, Medicinal Chemistry Research, vol. 25, no. 4, pp. 790-804, 2016.
P. S. Mahajan, Nikam, M. D., Khedkar, V. M., Jha, P. C., Sarkar, D., and Gill, C. H., “Synthesis, biological evaluation and molecular docking studies of N-acylheteroaryl hydrazone derivatives as antioxidant and anti-inflammatory agents”, Research on Chemical Intermediates, vol. 42, no. 3, pp. 2707-2729, 2016.
N. C. Desai, Somani, H., Trivedi, A., Bhatt, K., Nawale, L., Khedkar, V. M., Jha, P. C., and Sarkar, D., “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.
R. Singh, Nawale, L., Sarkar, D., and Suresh, C. G., “Two chitotriose-specific lectins show anti-angiogenesis, induces caspase-9-mediated apoptosis and early arrest of pancreatic tumor cell cycle”, Plos One, vol. 11, no. 1, p. Article Number: e0146110, 2016.
2015
M. H. Shaikh, Subhedar, D. D., Nawale, L., Sarkar, D., Khan, F. A. Kalam, Sangshetti, J. N., and Shingate, B. B., “1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study”, MedChemComm, vol. 6, no. 6, pp. 1104-1116, 2015.
S. Akhtar, Singh, S., Kumar, S., and Sarkar, D., “Analyzing different acetyl co-a metabolizing enzymes as potential drug targets against mycobacterium tuberculosis”, British Microbiology Research Journal, vol. 10, no. 4, pp. 1-15, 2015.
A. A. Chinchansure, Shamnani, N., Arkile, M. A., Sarkar, D., and Joshi, S. P., “Antimycobacterium activity of coumarins from fruit pulp of aegle marmelos (L.) correa”, International Journal of Basic and Applied Chemical Sciences, vol. 5, no. 3, pp. 39-44, 2015.

Pages